AZAHETEROCYCLYL DERIVATIVES OF ANDROSTANES AND ANDROSTENES AS MEDICAMENTS FOR CARDIOVASCULAR DISORDERS
申请人:Cerri Alberto
公开号:US20090275542A1
公开(公告)日:2009-11-05
Compounds of formula (I) wherein: the groups are as defined in the description, are useful for the preparation of medicaments for the treatment of cardiovascular disorders, in particular heart failure and hypertension. The compounds are inhibitors of the enzymatic activity of the Na+, K+-ATPase. They are useful for the preparation of a medicament for the treatment of a disease caused by the hypertensive effects of endogenous ouabain, such as renal failure progression in autosomal dominant polycystic renal disease (ADPKD), preeclamptic hypertension and proteinuria and renal failure progression in patients with adducin polymorphisms.
式(I)化合物,其中:所述基团如描述中定义的那样,对于制备治疗心血管疾病的药物,特别是心力衰竭和高血压是有用的。这些化合物是Na+,K+-ATPase酶活性的抑制剂。它们对于制备治疗内源性欧巴因引起的疾病的药物是有用的,例如:常染色体显性多囊肾病(ADPKD)中的肾功能衰竭进展、先兆子痫性高血压和蛋白尿,以及具有adducin多态性的患者的肾功能衰竭进展。